Literature DB >> 14734606

Impaired IFN-gamma production of Valpha24 NKT cells in non-remitting sarcoidosis.

Seiichiro Kobayashi1, Yoshikatsu Kaneko, Ken-Ichiro Seino, Yoshihito Yamada, Shinichiro Motohashi, Junzo Koike, Kaoru Sugaya, Takayuki Kuriyama, Shigetaka Asano, Tomiyasu Tsuda, Hiroshi Wakao, Michishige Harada, Satoshi Kojo, Toshinori Nakayama, Masaru Taniguchi.   

Abstract

Sarcoidosis is a systemic disorder associated with granuloma characterized by an abnormal T(h)1-type cytokine production and accumulation of T(h)1 CD4 T cells in the granuloma lesions, suggesting an importance of T(h)1 responses in sarcoidosis. However, the pathogenesis of sarcoidosis remains to be solved. Here, we investigated the nature of V(alpha)24 NKT cells with immunoregulatory functions in sarcoidosis. Patients with non-remitting sarcoidosis displayed a decrease in the number of V(alpha)24 NKT cells in peripheral blood, but an accumulation of these cells in granulomatous lesions. When stimulated with the specific glycolipid ligand, alpha-galactosylceramide, peripheral blood V(alpha)24 NKT cells from patients with non-remitting disease produced significantly less IFN-gamma than those from healthy volunteers, but normal levels of IL-4. The reduced IFN-gamma production was observed only in V(alpha)24 NKT cells and not conventional CD4 T cells, but was normal in patients with remitting disease, suggesting that non-remitting sarcoidosis involves an insufficient IFN-gamma production of V(alpha)24 NKT cells which is well correlated with disease activity. Thus, these results suggest that V(alpha)24 NKT cells play a crucial role in the disease status of sarcoidosis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14734606     DOI: 10.1093/intimm/dxh020

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  11 in total

1.  Analysis of invariant natural killer T cells in human paracoccidioidomycosis.

Authors:  Vanessa Gomes Batista; Lúcia Moreira-Teixeira; Maria C Leite-de-Moraes; Gil Benard
Journal:  Mycopathologia       Date:  2011-07-30       Impact factor: 2.574

2.  Circulating cytokines in sarcoidosis: phenotype-specific alterations for fibrotic and non-fibrotic pulmonary disease.

Authors:  Karen C Patterson; Beverly S Franek; Joachim Müller-Quernheim; Anne I Sperling; Nadera J Sweiss; Timothy B Niewold
Journal:  Cytokine       Date:  2013-02-04       Impact factor: 3.861

Review 3.  Role of CD4+ T cells in sarcoidosis.

Authors:  Johan Grunewald; Anders Eklund
Journal:  Proc Am Thorac Soc       Date:  2007-08-15

4.  Invariant natural killer T (iNKT) cell exhaustion in sarcoidosis.

Authors:  Jennifer E Snyder-Cappione; Douglas F Nixon; Joyce C Chi; Michelle-Linh T Nguyen; Christopher K Kirby; Jeffrey M Milush; Laura L Koth
Journal:  Eur J Immunol       Date:  2013-06-25       Impact factor: 5.532

Review 5.  Sarcoidosis: Immunopathogenesis and Immunological Markers.

Authors:  Wei Sheng Joshua Loke; Cristan Herbert; Paul S Thomas
Journal:  Int J Chronic Dis       Date:  2013-07-25

6.  Accumulation of invariant NKT cells with increased IFN-γ production in persistent high-risk HPV-infected high-grade cervical intraepithelial neoplasia.

Authors:  Ting Hu; Pei Yang; Hongmei Zhu; Xinlian Chen; Xiaoyan Xie; Mei Yang; Shanling Liu; He Wang
Journal:  Diagn Pathol       Date:  2015-04-02       Impact factor: 2.644

7.  Disposal of iNKT cell deficiency and an increase in expression of SLAM signaling factors characterizes sarcoidosis remission: a 4-year longitudinal study.

Authors:  Katarina Osolnik; Matija Rijavec; Peter Korosec
Journal:  Respir Res       Date:  2014-08-21

8.  Activation of mucosal-associated invariant T cells in the lungs of sarcoidosis patients.

Authors:  Hisayo Matsuyama; Takuma Isshiki; Asako Chiba; Tetsuo Yamaguchi; Goh Murayama; Yoshikiyo Akasaka; Yoshinobu Eishi; Susumu Sakamoto; Sakae Homma; Sachiko Miyake
Journal:  Sci Rep       Date:  2019-09-12       Impact factor: 4.379

9.  Abnormalities in iNKT cells are associated with impaired ability of monocytes to produce IL-10 and suppress T-cell proliferation in sarcoidosis.

Authors:  Anjali Crawshaw; Yvonne R Kendrick; Andrew J McMichael; Ling-Pei Ho
Journal:  Eur J Immunol       Date:  2014-05-12       Impact factor: 5.532

Review 10.  Biomarkers in the Diagnosis and Prognosis of Sarcoidosis: Current Use and Future Prospects.

Authors:  Raisa Kraaijvanger; Montse Janssen Bonás; Adriane D M Vorselaars; Marcel Veltkamp
Journal:  Front Immunol       Date:  2020-07-14       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.